Heska Corporation (NASDAQ: HSKA) seeks to enhance shareholder value through exceptional business practices and operational performance, strong governance, responsible reporting, and effective communication and engagement. Heska actively engages the public market with timely reporting, relevant presentations and events, and other important financial data and filings.
Heska Corporation (NASDAQ: HSKA) manufactures, develops and sells advanced veterinary diagnostic and specialty healthcare products through its two business segments: North America and International. Both segments include Point of Care Lab testing instruments and consumables, digital imaging products, software and services, data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. The North America segment also includes private label vaccine and pharmaceutical production under third-party agreements and channels, primarily for herd animal health.
- Heska Corporation Fourth Quarter and Full Year 2022 Earnings Call WebcastHeska Corporation Fourth Quarter and Full Year 2022 Earnings Call… (February 28, 2023 11:00 AM ET)
- J.P. Morgan Health Care Conference Presentation41st Annual J.P. Morgan Healthcare Conference (January 11, 2023 12:45 PM ET)
- Heska Corporation Third Quarter 2022 Earnings Call WebcastHeska Corporation Third Quarter 2022 Earnings Call Webcast (November 8, 2022 11:00 AM ET)
- Heska Corporation Second Quarter 2022 Earnings Call WebcastHeska Corporation Second Quarter 2022 Earnings Call Webcast (August 8, 2022 11:00 AM ET)
- Stifel 2022 Jaws & Paws ConferenceStifel 2022 Jaws & Paws Conference (June 1, 2022 3:00 PM ET)
Please fill out the form below to receive company press releases and other information via email when they occur.